Total Funding
42
Total FundingSeries A raised
Growth Score
pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
65130
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
David Maizenberg: Co-Founder and General CounselPast Role: Fish & Richardson P.C., Director of Marketing and Business Development
Tatyana Touzova: Chief Operating Officer
About the Company
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
ValenzaBio implements biomarker-driven approaches to guide research and clinical development. Our pipeline includes several monoclonal antibodies targeting surface antigens to reduce pathogenic subpopulations of autoreactive cells.
Our most advanced program has generated Phase 1 proof-of-concept in patients and we’re progressing preclinical programs focused on differentiated mechanisms of action. Our mission is to provide safe and effective treatment options for patients with unmet needs.
